期刊
DEVELOPMENT
卷 144, 期 17, 页码 3114-3125出版社
COMPANY BIOLOGISTS LTD
DOI: 10.1242/dev.150656
关键词
Schwann cell; Myelination; Sox2; Repair; Peripheral nervous system; Mouse
资金
- Wellcome Trust [088228/Z/09/Z]
- Fondazione Telethon [GGP14147]
- Italian Ministry of Health (Ministero della Salute) [GR-2011-02346791]
- Wellcome Trust [088228/Z/09/Z] Funding Source: Wellcome Trust
- Cancer Research UK [17135, 11244] Funding Source: researchfish
- Medical Research Council [MR/N009169/1] Funding Source: researchfish
- MRC [MR/N009169/1] Funding Source: UKRI
Correct myelination is crucial for the function of the peripheral nervous system. Both positive and negative regulators within the axon and Schwann cell function to ensure the correct onset and progression of myelination during both development and following peripheral nerve injury and repair. The Sox2 transcription factor is well known for its roles in the development and maintenance of progenitor and stem cell populations, but has also been proposed in vitro as a negative regulator of myelination in Schwann cells. We wished to test fully whether Sox2 regulates myelination in vivo and show here that, in mice, sustained Sox2 expression in vivo blocks myelination in the peripheral nerves and maintains Schwann cells in a proliferative non-differentiated state, which is also associated with increased inflammation within the nerve. The plasticity of Schwann cells allows them to re-myelinate regenerated axons following injury and we show that re-myelination is also blocked by Sox2 expression in Schwann cells. These findings identify Sox2 as a physiological regulator of Schwann cell myelination in vivo and its potential to play a role in disorders of myelination in the peripheral nervous system.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据